潘文志,葛均波

• 1:复旦大学附属中山医院心内科

摘要(Abstract)：

<正>经导管主动脉瓣置入术(TAVI)从一诞生就备受关注,近几年已然成为介入心脏病学一颗璀璨"明星"。虽然不像前几年有PARTNER那样重磅级的研究公布,但2013年TAVI还是取得一定进展。本文拟回顾2013年TAVI主要研究进展,并对其前景做出展望。一、当前技术情况目前为止,全球已完成TAVI超13万例。在欧美等技术成熟地区,TAVI已成为常规治疗手段,在某些中心TAVI已占到所有主动脉瓣置换术的30%～40%。TAVI目前也正在亚洲、澳洲、南美洲迅速推广。2013年,欧美各公布了1个大型的注册研究,其结果代表了当前TAVI的

关键词(KeyWords)： 经导管主动脉瓣置入术

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 潘文志,葛均波

参考文献(References)：

• [1]Di Mario C,Eltchaninoff H,Moat N,et al.The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation:in-hospital results in 4571 patients.EuroIntervention,2013,8:1362-1371.
• [2]Mack MJ,Brennan JM,Brindis R,et al.Outcomes following transcatheter aortic valve replacement in the United States.JAMA,2013,310:2069-2077.
• [3]Gilard M,Eltchaninoff H,Iung B,et al.Registry of transcatheter aortic-valve implantation in high-risk patients.N Engl J Med,2012,366:1705-1715.
• [4]Toggweiler S,Humphries KH,Lee M,et al.5-year outcome after transcatheter aortic valve implantation.J Am Coll Cardiol,2013,61:413-419.
• [5]Wenaweser P,Stortecky S,Schwander S,et al.Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation.Eur Heart J,2013,34:1894-1905.
• [6]Piazza N,Kalesan B,van Mieghem N,et al.A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients.JACC Cardiovasc Interv,2013,6:443-451.
• [7]D'Errigo P,Barbanti M,Ranucci M,et al.Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis:Results from an intermediate risk propensitymatched population of the Italian OBSERVANT study.Int J Cardiol,2013,167:1945-1952.
• [8]周达新,潘文志,管丽华,等.经导管瓣中瓣置入治疗人工生物主动脉瓣反流一例.中华心血管病杂志,2013,41:800-801.
• [9]Roy DA,Schaefer U,Guetta V,et al.Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.J Am Coll Cardiol,2013,61:1577-1584.
• [10]周达新,潘文志,管丽华,等.经导管主动脉瓣置入治疗二叶式钙化性主动脉瓣狭窄一例报道.中国介入心脏病学杂志,2013,21:127-128.
• [11]Schofer J,Colombo A,Klugmann S,et al.Prospective Multicenter Evaluation of the Direct Flow Medical?Transcatheter Aortic Valve.J Am Coll Cardiol,2013 Oct 22.[Epub ahead of print].
• [12]Meredith Am IT,Worthley SG,Whitbourn RJ,et al.Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients:the REPRISE I study.EuroIntervention,2013 Oct 31.[Epub ahead of print].
• [13]Barbanti M,Leipsic J,Binder R,et al.Underexpansion and Ad Hoc Post-dilation in Selected Patients Undergoing Balloon-Expandable Transcatheter Aortic Valve Replacement.J Am Coll Cardiol,2013Oct 22.[Epub ahead of print]
• [14]Nijhoff F,Agostoni P,Samim M,et al.Optimisation of transcatheter aortic balloon-expandable valve deployment:the two-step infl ation technique.EuroIntervention,2013,9:555-563.
• [15]Mendiz OA,Fraguas H,Lev GA,et al.Transcatheter aortic valve implantation without balloon predilation:A single-center pilot experience.Catheter Cardiovasc Interv,2013,82:292-297.